A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin

Clinical trial NCT01624025 · COMPLETED

Trial details

NCT number: NCT01624025
Sponsor: Yonsei University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Advanced Gastric Cancer

Start date: 2012-06-01
Primary completion: 2015-09-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.